Athyrium Capital Management, LP Q2 2024 13F 持股明细 | AlphaSMO

Athyrium Capital Management, LP — Q2 2024 13F 持股

Name: Athyrium Capital Management, LP — 13F Holdings, Q2 2024
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001728001

申报总市值

US$86.9亿

本季完整持股清单

#	代码	标的名称	资产子类别	占比	占比变动	持仓量变化
1	CHRS 1.5 04-15-26	Coherus Oncology INC	股票-其他	—	—	—
2	✓	Biora Therapeutics INC	股票-其他	—	—	-100.00%
3	PBYI	Puma Biotechnology INC	股票-其他	—	—	-100.00%